Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Emerging therapy options for IgG4-related disease.

Lanzillotta M. et al, (2021), Expert review of clinical immunology, 17, 471 - 483

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.

Cargill T. and Culver EL., (2021), Frontiers in immunology, 12

Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'.

Peters RJR. et al, (2020), Annals of the rheumatic diseases

Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.

Culver EL. et al, (2020), Liver international : official journal of the International Association for the Study of the Liver, 40, 2744 - 2757

Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses.

Unger P-PA. et al, (2020), European journal of immunology, 50, 1113 - 1125

European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Löhr J-M. et al, (2020), United European gastroenterology journal, 8, 637 - 666

Review of primary sclerosing cholangitis with increased IgG4 levels.

Manganis CD. et al, (2020), World journal of gastroenterology, 26, 3126 - 3144

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

Goodchild G. et al, (2020), Clinical medicine (London, England), 20, e32 - e39

Expansion of a Novel Subset of PD1+CXCR5-CD4+ T Peripheral Helper Cells in IgG4-Related Disease.

Cargill T. et al, (2020), Clinical and translational gastroenterology, 11

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.

Wallace ZS. et al, (2020), Annals of the rheumatic diseases, 79, 77 - 87

IgG4-related disease

Culver EL. et al, (2019), Medicine (United Kingdom), 47, 804 - 807

Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis

Culver EL. et al, (2019), Journal of Gastroenterology and Hepatology, 34, 1878 - 1886

Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.

Cargill T. et al, (2019), Clinical and translational gastroenterology, 10

Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.

Camilleri M. et al, (2019), Clinical and translational gastroenterology, 10

Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.

Cargill T. et al, (2019), Clinical and translational gastroenterology

Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis

Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00020 - e00020

Evolving role of magnetic resonance techniques in primary sclerosing cholangitis

Selvaraj EA. et al, (2019), World Journal of Gastroenterology, 25, 644 - 658

Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort

Evans RDR. et al, (2019), Kidney International Reports, 4, 48 - 58

An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index

Wallace ZS. et al, (2018), Arthritis Care & Research, 70, 1671 - 1678

Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret

Zenouzi R. et al, (2018), Alimentary Pharmacology & Therapeutics, 48, 169 - 178

Load More

1
2
3
4
5

Include forthcoming?